Your browser doesn't support javascript.
loading
Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study.
Cartron, Guillaume; Letestu, Rémi; Dartigeas, Caroline; Tout, Mira; Mahé, Béatrice; Gagez, Anne-Laure; Ferrant, Emmanuelle; Guiu, Boris; Villemagne, Bruno; Letuan, Phan; Aurran, Thérèse; Orsini-Piocelle, Frédérique; Banos, Anne; Feugier, Pierre; Leblond, Véronique; de Guibert, Sophie; Tournilhac, Olivier; Dupuis, Jehan; Delmer, Alain; Rouillé, Valérie; Ternant, David; Leprêtre, Stéphane.
Afiliação
  • Cartron G; Department of clinical hematology, University hospital of Montpellier, France g-cartron@chu-montpellier.fr.
  • Letestu R; CNRS UMR 5235, University of Montpellier, France.
  • Dartigeas C; APHP, HUPSSD, Hospital Avicenne, Department of biological hematology, Bobigny, France.
  • Tout M; Department of clinical hematology, University hospital of Tours, France.
  • Mahé B; CNRS UMR 7292, François Rabelais University, University hospital of Tours, France.
  • Gagez AL; Department of clinical hematology, University hospital of Nantes, France.
  • Ferrant E; Department of clinical hematology, University hospital of Montpellier, France.
  • Guiu B; Department of clinical hematology, University hospital of Dijon, France.
  • Villemagne B; Department of Radiology, University hospital of Montpellier, France.
  • Letuan P; Department of hematology-oncology, Departmental Hospital La Roche-sur-Yon, France.
  • Aurran T; Laboratory of Biostatistics, University institute of Clinical Research, Montpellier, France.
  • Orsini-Piocelle F; Paoli Calmette Center, Marseille, France.
  • Banos A; Department of clinical hematology, Hospital of Annecy, France.
  • Feugier P; Department of clinical hematology, Hospital Côte Basque, Bayonne, France.
  • Leblond V; Department of clinical hematology, University hospital of Nancy, France.
  • de Guibert S; Department of clinical hematology, UPMC University of Paris 6, GRC11, Hospital La Pitié Salpêtrière, France.
  • Tournilhac O; Department of clinical hematology, University hospital of Rennes, France.
  • Dupuis J; Department of clinical hematology, University hospital of Clermont-Ferrand, France.
  • Delmer A; Fonctional unit Lymphoid malignancies, University hospital Henri Mondor, Créteil, France.
  • Rouillé V; Department of clinical hematology, University hospital of Reims, Rouen, France.
  • Ternant D; Department of clinical hematology, University hospital of Montpellier, France.
  • Leprêtre S; CNRS UMR 7292, François Rabelais University, University hospital of Tours, France.
Haematologica ; 103(8): e356-e359, 2018 08.
Article em En | MEDLINE | ID: mdl-29519866
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Rituximab Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Rituximab Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França